“On the 8th, Daewoong Pharmaceutical announced that they have signed a distribution agreement for the AI-based retinal disease diagnostic support solution ‘WISKY’ and the ocular camera ‘Optina Genesis’ with the medical device specialized company, Ark. Under this agreement, Daewoong Pharmaceutical will be responsible for the domestic distribution of WISKY and Optina, while Ark will handle the manufacturing, production, and technical support of the products.
WISKY is a retinal disease diagnostic platform utilizing AI that provides findings for the three major diseases causing blindness: diabetic retinopathy, age-related macular degeneration, and glaucoma. By integrating images taken with the ocular camera into the WISKY program, the AI algorithm analyzes the images to diagnose the disease.
WISKY can provide a rapid and effective diagnosis for medical professionals by interpreting retinal images within 3 to 5 seconds with just one click. Additionally, the diagnostic results are displayed with different colors for each lesion, allowing patients to easily understand and receive detailed explanations of the findings. Patients can also easily identify the lesion areas through image-based diagnostic reports.
Optina is a specialized camera designed for capturing images of the eye, allowing high-resolution imaging of internal eye structures, including the retina, choroid, and optic nerve for diagnosing and managing various ophthalmic conditions. Weighing approximately 2.7 kg, it is portable, and a single button press initiates automated imaging without the need for administering mydriatics for pupil dilation, enhancing patient convenience during examinations.
The CEO of Daewoong Pharmaceutical, Lee Chang-jae, stated, “By combining the excellent technological capabilities of Optina and WISKY with Daewoong Pharmaceutical’s strong marketing expertise, we aim to provide more accurate and timely diagnoses to many patients, ultimately enabling early diagnosis and effective management of domestic eye diseases. Daewoong Pharmaceutical will continue to actively introduce innovative medical solutions to contribute to public health.”
Daewoong Pharmaceutical also supplies digital medical devices such as the AI electrocardiogram wearable device ‘MobiCare’ and the ring-shaped continuous blood pressure monitor ‘CartBP’.”